Market Cap (In JPY)
9.7 Billion
Revenue (In JPY)
2.42 Billion
Net Income (In JPY)
-31.41 Million
Avg. Volume
741.8 Thousand
- Currency
- JPY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 100.0-180.0
- PE
- -
- EPS
- -
- Beta Value
- 0.298
- ISIN
- JP3974770004
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Shuji Yokoyama Ph.D.
- Employee Count
- -
- Website
- https://www.reprocell.com
- Ipo Date
- 2013-06-26
- Details
- ReproCELL Incorporated operates as a stem cell research company in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, pluripotent stem cell culture media, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, and induced neurons; and 3D cell culture; and labware. The company also provides preclinical genomics, stem cell research, drug efficacy, safety, & ADME, human tissue samples, therapeutic pipeline, clinical laboratory services, clinical diagnostic services, and gmp ipsc master cell bank services. ReproCELL Incorporated was incorporated in 2003 and is based in Yokohama, Japan.
More Stocks
-
BVFLBV Financial, Inc.
BVFL
-
189AD&M COMPANY CO LTD
189A
-
004545KleanNara Co., Ltd.
004545
-
CAPC
-
605266
-
BWF
-
9296RCE Capital Berhad
9296
-
FASFastenal Company
FAS